Work

Supplemental Table S1. from A Phase I, Dose-Finding Study in Patients with Advanced Solid Malignancies of the Oral γ-Secretase Inhibitor PF-03084014

Year: 2023

Type: supplementary-materials

Abstract: Supplemental Table S1. Tumor responses to single-agent treatment with PF-03084014 in patients with advanced solid malignancies.

DOI: 10.1158/1078-0432.22455392.v1

Authors: Wells A. Messersmith, Geoffrey I. Shapiro, James M. Cleary, Antonio Jimeno, Arvind Dasari, Bo Huang, M. Naveed Shaik, Rossano Cesari, Xianxian Zheng, Jennifer M. Reynolds, Patricia A. English, Karen R. McLachlan, Kenneth A. Kern, Patricia M. LoRusso

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361910357

Cites:

Cited by:

Related to: 10